{"id":7442,"date":"2019-07-19T00:00:00","date_gmt":"2019-07-18T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/blog\/2019\/07\/19\/extended-deadline-expression-of-interest-eoi-for-collaborative-projects-on-regenerative-medicine\/"},"modified":"2020-11-19T15:08:36","modified_gmt":"2020-11-19T14:08:36","slug":"extended-deadline-expression-of-interest-eoi-for-collaborative-projects-on-regenerative-medicine","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2019\/07\/extended-deadline-expression-of-interest-eoi-for-collaborative-projects-on-regenerative-medicine\/","title":{"rendered":"EXTENDED DEADLINE — Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine"},"content":{"rendered":"

1.- Background<\/p>\n

The Centre for Regenerative Medicine of Barcelona (CMR[B]), together with the Biomedical\u00a0Research Institute of Bellvitge (IDIBELL), at the behest of the Catalan Government(1), have\u00a0launched the Program for advancing the Clinical Translation of Regenerative Medicine of\u00a0Catalonia \u2013 P-CMR[C].\u00a0The fundamental mission of the P-CMR[C] is to advance the implementation of regenerative\u00a0medicine strategies by conducting research of excellence to address the current bottlenecks\u00a0that prevent the clinical translation of pluripotent stem cell (PSC)-based therapies. The P-CMR[C] aims to nucleate and catalyze research on regenerative medicine based on PSC\u00a0in Catalonia. Research at P-CMR[C] targets unmet medical needs tractable by regenerative medicine strategies. Research projects at P-CMR[C] aim at excellence; we seek new concepts, novel enabling technologies, fundamental discoveries, proof-of-principle evidence, first-in-man\u00a0trials. We value quality over quantity. Our projects are intended to use state-of-the-art\u00a0technologies. Based on prior scientific knowledge, outstanding bottlenecks to be solved, societal impact, and strategic opportunity, first-choice targets include: i) heart failure; ii)\u00a0neurodegenerative diseases; iii) non-malignant hematological diseases; and iv) age-related\u00a0macular degeneration. However, other scientifically sound scenarios designed to address unmet medical needs by means of PSC-based regenerative medicine approaches will be considered as well.<\/p>\n

We believe that the establishment of high-quality scientific criteria, based on a real complementarity of action among the different relevant stakeholders within Catalonia, and with unequivocal orientation towards the clinical applicability of the findings, will help improving the\u00a0quality of life of patients.<\/p>\n

An Advisory Body consisting on representatives of the Catalan Healthcare Research Centers\u00a0certified by the Instituto de Salut Carlos III (Catalan IIS Centers), representatives of the Health\u00a0Department from the Generalitat de Catalunya, and representatives of the CMR[B], will be\u00a0appointed to guide the implementation of the P-CMR[C].<\/p>\n

2.- Aim of the EoI<\/p>\n

The P-CMR[C] is seeking to map in detail the research and development capabilities on\u00a0regenerative medicine approaches across Catalonia2. To this end, we hereby invite for\u00a0Expressions of Interest (EoI) regarding collaborative efforts planning to develop goal-oriented\u00a0projects in the field of regenerative medicine. EoI must involve at least three research groups\u00a0spanning the relevant basic, applied, and\/or clinical expertise within the Catalan Ecosystem\u00a0(see eligibility criteria below).<\/p>\n

EoI are intended to provide an inventory of the research groups existing in the Catalan research\u00a0ecosystem who wish to align their efforts with those of other research groups in order to develop\u00a0strategies of regenerative medicine in a collaborative manner. Proposals are expected to be\u00a0interdisciplinary and clearly demonstrate the potential impact in regenerative medicine as well\u00a0as the added value of the proposed collaboration.<\/p>\n

The P-CMR[C] will select up to 10 outstanding EoI based on their ability to identify a clinically\u00a0relevant paradigm tractable by regenerative medicine approaches, and to propose a research\u00a0project addressing the outstanding bottlenecks that preclude their clinical implementation. The
\nP-CMR[C] will establish collaborative agreements with the Institutions proposing the selected\u00a0EoI and will finance up to 10,000 \u20ac to help consolidating the collaborative effort.<\/p>\n

3.- General eligibility criteria for application<\/p>\n

EoI should meet the following eligibility criteria:<\/p>\n

\u2022 Should be comprised of at least three research groups based on Catalonia (at least three different principal investigators)
\n\u2022 Should be comprised of at least two different research centers
\n\u2022 The project coordinator (principal investigator) should belong to a Catalan IIS Center
\n\u2022 The project coordinator can only participate in one EoI<\/p>\n

4.- How to apply<\/p>\n

Documentation needed:<\/p>\n

\u2022 Application form: Including a description of the research groups participating in the\u00a0collaborative effort and a brief description of the project proposal (relevant question\u00a0related to regenerative medicine the groups want to tackle).
\n\u2022 Standardized short CV: (CVA \u2013 CNV format) of all the group leaders participating in\u00a0the collaborative effort. Please provide only a selected list of 10 publications within\u00a0the CVA.
\n\u2022 Declaration form from the Research Centers participating in the collaborative effort.<\/p>\n

All documentation must be written in English. The call forms are available at the following link:\u00a0https:\/\/cmrb.eu\/media\/upload\/pdf\/pcmrc_eoi.pdf<\/a><\/p>\n

EoI for Collaborative efforts on Regenerative Medicine will be accepted exclusively when all the\u00a0requested documentation is presented in time and manner to pcmrc_eoi@cmrb.eu<\/a>. The\u00a0deadline for presenting EoI is July 31, 2019.<\/p>\n

Presenting an EoI implies authorization for P-CMR[C] to obtain and contrast the necessary data\u00a0on the applicants with the relevant public bodies, research centers, universities or institutes in\u00a0each case, in order to satisfactorily resolve the call. Likewise, P-CMR[C] is authorized to submit\u00a0the information to an external advisor if needed.<\/p>\n

5.- Prioritization of EoI<\/p>\n

EoI received by the deadline indicated above will be first screened for eligibility criteria. Those\u00a0that do not meet the eligibility criteria will be rejected.<\/p>\n

EoI meeting the eligibility criteria will be evaluated by the P-CMR[C] Advisory Body to select the\u00a0most outstanding proposals and prioritize funding according to the following criteria:<\/p>\n

\u2022 Participating groups (6 points out of 10):<\/p>\n

o Multidisciplinary of the research groups (including basic, translational, clinical
\nresearch groups) will be highly considered
\no Participation of private partners will also be considered
\no Leadership of the collaborative effort
\no CV of the participating PIs
\no Expertise of the groups relevant to regenerative medicine
\no Previous collaborations among research groups<\/p>\n

\u2022 Project proposal (4 points out of 10):
\no Excellence of the project proposal: clarity and pertinence of the objectives, as
\nwell as soundness and credibility of the concept
\no Expected Impact: The extent to which the output of the project would contribute
\nto advancing the clinical translation of regenerative medicine strategies
\no Level of ambition in the collaboration and commitment of the participants in the
\nproposed project<\/p>\n

The results of the EoI prioritization will be posted by September 18, 2019 on the CMR[B]\u00a0(www.cmrb.eu<\/a>) and IDIBELL (www.idibell.cat<\/a>) websites.<\/p>\n

6.- Main Duties of the selected collaborative efforts<\/p>\n

Funded EoI are expected to use the allocated funds for activities that consolidate their collaborative efforts. Such activities include (but are not restricted to): organization of\u00a0brainstorming meetings, generation of preliminary results supporting their working hypotheses,\u00a0preparation of joint proposals for competitive calls, etc. The project coordinator (principal\u00a0investigator) will be responsible for budget allocation and management.<\/p>\n

(1)\u00a0Approved by \u201cAcord de Govern de la Generalitat de Catalunya\u201d on October 6th 2015.<\/p>\n

(2)\u00a0This was approved by CMR[B]\u2019s Board of Trustees on December 19th 2018.<\/p>\n

 <\/p>\n

Project cofunded by:<\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

1.- Background The Centre for Regenerative Medicine of Barcelona (CMR[B]), together with the Biomedical\u00a0Research Institute of Bellvitge (IDIBELL), at the behest of the Catalan Government(1), have\u00a0launched the Program for advancing the Clinical Translation of Regenerative Medicine of\u00a0Catalonia \u2013 P-CMR[C].\u00a0The fundamental mission of the P-CMR[C] is to advance the implementation of regenerative\u00a0medicine strategies by conducting research […]<\/p>\n","protected":false},"author":6,"featured_media":10459,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[349],"tags":[94],"publishpress_future_action":{"enabled":false,"date":"2024-05-12 10:59:24","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7442"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=7442"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7442\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/10459"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=7442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=7442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=7442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}